| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/31/2006 | US6991928 Peptide for use in the treatment of inflammation, cancer, arteriosclerosis and psoriasis |
| 01/31/2006 | US6991924 Mutant carbamoylphosphate synthetase and method for producing compounds derived from carbamoylphosphate |
| 01/31/2006 | US6991922 Process for in vitro creation of recombinant polynucleotide sequences by oriented ligation |
| 01/31/2006 | US6991921 Hyaluronan synthase gene and uses thereof |
| 01/31/2006 | US6991920 Peptide for use in human therapeutics and diagnostics |
| 01/31/2006 | US6991916 Nucleotide sequences coding polypeptide for use in the treatment of sexual disorders |
| 01/31/2006 | US6991908 Antiobestic agents methods for screening antiobestic agents and kits comprising same |
| 01/31/2006 | US6991904 Method for isolating a polynucleotide of interest from the genome of a mycobacterium using a BAC-based DNA library: application to the detection of mycobacteria |
| 01/31/2006 | US6991901 Administering an antibody to the polypeptide sec1; angiogenesis inhibitors |
| 01/31/2006 | US6991900 Detecting preferential gene expression in bacterial cells; obtain cells, transform with artifical bacterial chromosome, detect transposon and preferential gene expression in transformed cells |
| 01/31/2006 | US6991899 transgenic mink lung cells (which express human furin) which show increased sensitivity to infection or are capable of enhanced productivity of infectious virion; drug screening; kits; vaccines |
| 01/31/2006 | US6991824 Expression of human milk proteins in transgenic plants |
| 01/31/2006 | US6991796 Platlet glycoprotein IBα fusion polypeptides and methods of use thereof |
| 01/31/2006 | US6991794 FRIL family of factors and nucleic acids encoding the same; use as therapeutics for alleviating and/or reducing the hematopoietic progenitor cell-depleting activity of many cancer therapeutics |
| 01/31/2006 | US6991792 Genetically engineered vaccinia virus fror use in the prevention of diabetes |
| 01/31/2006 | US6991788 Utilization of wolinella succinogenes asparaginase to treat diseases associated with asparagine dependence |
| 01/31/2006 | US6991787 expanding cells in culture, transfecting cells with an exogenous gene, and cryopreserving the cells; suitable for use in transplantation and gene therapy; storage stability |
| 01/31/2006 | US6991786 Anti-microbial biotherapeutic agents: alternatives to conventional pharmaceutical antibiotics |
| 01/31/2006 | US6991712 Using multiple color calibration standard of a mixture of polynucleotides of different length, each labeled with a spectrally distinct fluorescent dye; computerized |
| 01/31/2006 | CA2406381C Maize cellulose synthases and uses thereof |
| 01/31/2006 | CA2390104C Method for transfer of molecular substances with prokaryotic nucleic acid-binding proteins |
| 01/31/2006 | CA2339483C Maize cellulose synthases and uses thereof |
| 01/30/2006 | CA2510809A1 Chimpanzee trace amine associated receptors |
| 01/26/2006 | WO2006010147A2 Control of biofilm formation |
| 01/26/2006 | WO2006010138A1 Bioactive chemokine heteromultimers |
| 01/26/2006 | WO2006010106A2 Dna-based vaccination of retroviral-infected individuals undergoing treatment |
| 01/26/2006 | WO2006010096A2 Genetic manipulation of condensed tannins |
| 01/26/2006 | WO2006009922A2 Biological containment system |
| 01/26/2006 | WO2006009843A2 Negative regulation of hypoxia inducible factor 1 by os-9 |
| 01/26/2006 | WO2006009659A2 Galactinol synthases from soybean (glycine max) |
| 01/26/2006 | WO2006009575A1 METHODS OF INHIBITING TUMOR CELL PROLIFERATION WITH FOXM1 siRNA |
| 01/26/2006 | WO2006009559A1 Delivery of bioactive substances to target cells |
| 01/26/2006 | WO2006009533A1 Anti-glycated cd59 antibodies and uses thereof |
| 01/26/2006 | WO2006009330A1 Compositions and methods of using a regulator of biopolymer production |
| 01/26/2006 | WO2006009297A1 Construction of chimera using es cells |
| 01/26/2006 | WO2006009291A1 Method of inducing the differentiation of mesenchymal stem cell into odontoblast cell |
| 01/26/2006 | WO2006009260A1 Method of detecting hepatitis e virus |
| 01/26/2006 | WO2006009241A1 Lrp4/CORIN DOPAMINE-PRODUCING NEURON PRECURSOR CELL MARKER |
| 01/26/2006 | WO2006009114A1 Il-18 receptor antagonist and pharmaceutical composition containing the antagonist |
| 01/26/2006 | WO2006008881A1 Peroral vaccine carrier system |
| 01/26/2006 | WO2006008649A1 Anti-sense polynucleotide therapy for gastrin-promoted tumors |
| 01/26/2006 | WO2006008513A1 Modified virus |
| 01/26/2006 | WO2006008484A2 Detection of cellular stress |
| 01/26/2006 | WO2006008468A2 Adenovirus vector and method to manipulate the adenovirus genome |
| 01/26/2006 | WO2006008379A1 Recombinant endofucanase |
| 01/26/2006 | WO2006008154A1 mRNA MIXTURE FOR VACCINATING AGAINST TUMORAL DISEASES |
| 01/26/2006 | WO2006008142A1 Diagnosis and therapy of psoriasis vulgaris |
| 01/26/2006 | WO2006008102A1 P2-10 expression units |
| 01/26/2006 | WO2006008097A2 Pef-ts expression units comprising corynebacterium glutamicum |
| 01/26/2006 | WO2006008078A1 Immunogenic peptides, nucleic acids encoding the same and use thereof in cancer treatment and diagnosis |
| 01/26/2006 | WO2006008074A1 Gene therapy of solid tumours by means of retroviral vectors pseudotyped with arenavirus glycoproteins |
| 01/26/2006 | WO2006007712A1 Methods comprising polyethylene glycol-lipid conjugates for delivery of therapeutic agents |
| 01/26/2006 | WO2005118809A3 Methods and compositions for enhancing cell adhesion properties |
| 01/26/2006 | WO2005116214A3 Destructive insect-inducible promoters and uses thereof |
| 01/26/2006 | WO2005116203A3 Method and apparatus for bacterial transformation by electroporation with waveforms incorporating pulsed rf between 3 and 125 mhz |
| 01/26/2006 | WO2005108562A3 Synthetic fluorouridine-activating enzyme for cancer therapy |
| 01/26/2006 | WO2005103272A3 Pan cancer oncolytic vectors and methods of use thereof |
| 01/26/2006 | WO2005100572A3 Method for obtaining a stable gene silencing in eukaryotic cells |
| 01/26/2006 | WO2005090552A3 Method of engineering a cytidine monophosphate-sialic acid synthetic pathway in fungi and yeast |
| 01/26/2006 | WO2005086922A3 Oncolytic adenovirus armed with therapeutic genes |
| 01/26/2006 | WO2005086595A3 Telomere protein trf2 dna-binding domain mutant protein, telomere dna mutant and utilization of complex structure of trf2 dna-binding domain with double-stranded dna |
| 01/26/2006 | WO2005084412A3 Controlled modulation of the pharmacokinetics and biodistribution of aptamer therapeutics |
| 01/26/2006 | WO2005080565A8 Dna array for analyzing dna methylation, method of constructing the same and mehtod of analyzing dna methylaion |
| 01/26/2006 | WO2005079168A3 A novel stay-green gene and method for preparing stay-green transgenic plants |
| 01/26/2006 | WO2005072100A3 Generation of plants with altered oil content |
| 01/26/2006 | WO2005055979A3 Ph triggerable polymeric particles or films containing a poly (beta-amino ester) |
| 01/26/2006 | WO2005049817A3 Self-cleaving ribozymes and uses thereof |
| 01/26/2006 | WO2004113494A3 Methods for producing preparations of recombinant aav virions substantially free of empty capsids |
| 01/26/2006 | WO2004098534A3 Methods for delivering angiogenic modulators using pox viruses |
| 01/26/2006 | WO2004098532A3 Methods of reducing an immune response |
| 01/26/2006 | WO2004086853A3 Generation of plants with improved pathogen resistance |
| 01/26/2006 | WO2004076636A3 A novel human g-protein coupled receptor, hgprbmy23, expressed highly in kidney |
| 01/26/2006 | WO2004035010A3 Methods and organisms for production of B6 vitamers |
| 01/26/2006 | WO2004018630A3 Recombinant double-stranded rna phages and uses thereof |
| 01/26/2006 | WO2004013160A3 Protein transducing domain/deaminase chimeric proteins, related compounds, and uses thereof |
| 01/26/2006 | WO2002063032A9 Methods and kits for identifying scavengers of reactive oxygen species (ros) |
| 01/26/2006 | US20060021096 Genes encoding proteins with pesticidal activity |
| 01/26/2006 | US20060021095 Synthetic DNA sequence having enhanced insecticidal activity in maize |
| 01/26/2006 | US20060021094 Transgenic plant comprising vector expressing glyphosate resistance-conferring decarboxylase gene (GDC2) gene; glyphosate tolerant crops |
| 01/26/2006 | US20060021093 GDC-1 genes conferring herbicide resistance |
| 01/26/2006 | US20060021092 Stress tolerance and delayed senescence in plants |
| 01/26/2006 | US20060021091 Maize bZIP transcription factors and genes encoding the same and use thereof |
| 01/26/2006 | US20060021090 Soy compositions having improved organoleptic properties and methods of generation |
| 01/26/2006 | US20060021089 Methods for modifying plant characteristics |
| 01/26/2006 | US20060021088 Identification of novel e2f target genes and use thereof |
| 01/26/2006 | US20060021087 Compositions and methods for control of insect infestations in plants |
| 01/26/2006 | US20060021086 Nutritional supplements containing methylselenocysteine |
| 01/26/2006 | US20060021085 Method for producing transgenic plants having an elevated vitamin E content by modifying the serine-acetyltransferase content |
| 01/26/2006 | US20060021084 Production of peroxidase from plant cell and callus cultures |
| 01/26/2006 | US20060021083 Promoter, promoter control elements, and combinations, and uses thereof |
| 01/26/2006 | US20060021082 Cytokinin oxidase sequences and methods of use |
| 01/26/2006 | US20060021079 Promoter sequences providing male tissue-preferred expression in plants |
| 01/26/2006 | US20060021076 Prenatal screening |
| 01/26/2006 | US20060021073 Noc2 knockout mouse |
| 01/26/2006 | US20060020399 Method of mapping cDNA sequences |
| 01/26/2006 | US20060020125 Novel human membrane proteins and polynucleotides encoding the same |
| 01/26/2006 | US20060020123 Gene encoding a protein having aurone synthesis activity |
| 01/26/2006 | US20060020122 Xylanase, microorganisms producing it, DNA molecules, methods for preparing this xylanase and uses of the latter |
| 01/26/2006 | US20060020116 Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules |
| 01/26/2006 | US20060020114 Apo-2DcR |